UTRS Key Statistics, Chart & Performance
The current stock price of UTRS is 1.48 USD. In the past month the price decreased by -5.13%. In the past year, price decreased by -66.88%.
UTRS Technical Analysis
UTRS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to UTRS. UTRS may be in some trouble as it scores bad on both profitability and health.
UTRS Financial Highlights
Over the last trailing twelve months UTRS reported a non-GAAP Earnings per Share(EPS) of -8.21. The EPS increased by 58.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -45.95% | ||
| ROE | -164.78% | ||
| Debt/Equity | 1.37 |
UTRS Forecast & Estimates
7 analysts have analysed UTRS and the average price target is 3.06 USD. This implies a price increase of 106.76% is expected in the next year compared to the current price of 1.48.
For the next year, analysts expect an EPS growth of 82.41% and a revenue growth 2.99% for UTRS
UTRS Ownership
UTRS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.01 | 189.572B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.2 | 169.763B | ||
| SYK | STRYKER CORP | 23.86 | 137.985B | ||
| BSX | BOSTON SCIENTIFIC CORP | 26.16 | 135.821B | ||
| BDX | BECTON DICKINSON AND CO | 13.75 | 58.939B | ||
| IDXX | IDEXX LABORATORIES INC | 42.69 | 50.51B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.73 | 47.643B | ||
| RMD | RESMED INC | 20.47 | 36.698B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.65 | 35.886B | ||
| DXCM | DEXCOM INC | 28.46 | 27.937B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About UTRS
Company Profile
Minerva Surgical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Redwood City, California and currently employs 174 full-time employees. The company went IPO on 2021-10-22. Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The company has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The company offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.
Company Info
MINERVA SURGICAL INC
101 Saginaw Drive
Redwood City CALIFORNIA US
Employees: 174
Phone: 16502843500
MINERVA SURGICAL INC / UTRS FAQ
Can you describe the business of MINERVA SURGICAL INC?
Minerva Surgical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Redwood City, California and currently employs 174 full-time employees. The company went IPO on 2021-10-22. Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The company has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The company offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.
What is the current price of UTRS stock?
The current stock price of UTRS is 1.48 USD. The price decreased by -4.52% in the last trading session.
Does UTRS stock pay dividends?
UTRS does not pay a dividend.
How is the ChartMill rating for MINERVA SURGICAL INC?
UTRS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists UTRS stock?
UTRS stock is listed on the Nasdaq exchange.
Can you provide the sector and industry classification for MINERVA SURGICAL INC?
MINERVA SURGICAL INC (UTRS) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the number of employees for MINERVA SURGICAL INC?
MINERVA SURGICAL INC (UTRS) currently has 174 employees.